Omada Health

1mo

🤝 Xealth is excited to officially welcome Omada Health to our partner community! Chronic condition management requires a robust team and plan that goes beyond the four walls of a clinic. Through this integration, we’ll work together to extend care options and clinical support for those managing these conditions. We look forward to partnering to drive improved patient and clinical experiences! hashtag#DigitalHealth hashtag#HealthcareInnovation hashtag#ChronicDiseaseManagement

Omada Health

1mo

Did you know Omada has highly qualified exercise specialists to support GLP-1 journeys? Omada’s exercise specialists like Karen Hartung RD, LD/N, CDCES, CPT work directly with members to help with important patient education topics like realistic, approachable strength training. The goal? To support our members in preserving muscle alongside their GLP-1 weight loss. As Karen explains, preserving muscle can help boost metabolism and potentially improve long-term weight loss outcomes. https://lnkd.in/dUUrZQq9

Omada Health

1mo

What an incredible last few days at hashtag#AHIP26! Our Omada team was on-site and on a mission to engage with healthcare’s top thought leaders, take on tough, timely issues in our Innovation Lounge, and connect with all who stopped by booth 1424 and Bar Parasol afterward. We left feeling inspired and energized by the engaging sessions, especially on topics like AI-powered care, closing gaps in coverage, and measuring performance-based value in digital health. If you were able to make it to Vegas for AHIP, what was your highlight? And if you didn’t make it, hope to see you next year!

Omada Health

1mo

Earlier this week we hosted “The Story Between Visits: A New Lens on Cardiometabolic Care,” a webinar in partnership with Employee Benefit News. Our moderator Kevin Masci, Pharm D spoke with panelists Ruth Patten and Tylane Garrett, MS, RDN, LD to unpack what the GLP‑1 era is revealing about the cardiometabolic health journeys of everyday people. Some highlights included exploring what happens between doctor visits, why population health‑level stats can miss critical day‑to‑day barriers people encounter, and how employers can look for care solutions that complement in-person care instead of adding fragmentation. Did you miss the webinar? We’ve got you covered. The full recording is now available: https://ow.ly/bh8x50Zbcpk

Omada Health

1mo

Limiting GLP-1 coverage may be linked to reduced employee satisfaction, increased burnout, and greater turnover risk, leaving benefits leaders with a difficult and urgent challenge: how to help more patients succeed with GLP-1s while managing clinical complexity, patient experience, and financial sustainability. Our latest GLP-1 patient survey uncovers four critical themes to consider when solving this dilemma: ✅️ Does your population have access to judgement-free obesity care? ✅️ Is there a clear care plan for patients after they’ve discontinued a GLP-1, so they can avoid weight regain? ✅️ Are rising out‑of‑pocket costs and coverage limits becoming a substantial burden on your population, impacting wellbeing and productivity? ✅️ Once the patient is prescribed a GLP-1, do they have between-visit support for nutrition, exercise, behavior change, and medication adherence? Read our 2026 GLP-1 patient survey to learn more: https://lnkd.in/dpNQNvYQ

Omada Health

1mo

Raise your hand if you’re in Las Vegas for #AHIP2026! Swing by booth 1424 to meet our team and hear how we’re connecting cardiometabolic care across one integrated platform—now expanded to include GLP-1 prescribing and specialized cholesterol care. Plus, we’re scheduling 1:1 convos at our in-booth Innovation Lounge to dig into the tough issues surrounding care fragmentation and cost. Stop on by, say hello, and sign up for a 1:1 strategy session!

Omada Health

1mo

📑 A signed contract should mean a patient can find their virtual care provider, reach them, and have the claim paid. What really happens 👉 Providers end up in network on paper but out of reach in practice. With CMS raising the bar for provider directory accuracy and transparency, and payers expanding contracting with virtual-first care providers, we need to ensure that providers are fully integrated, discoverable, and reimbursable for patients. DiMe's Post-Contracting Operational Readiness for Virtual-First Care project, with Omada Health as title sponsor, will convene payers, virtual-first care providers, and policy advisors to build a shared standard for what it takes to go from a signed contract to a provider patients can actually use. 🩺 This builds on our Virtual-First Care Coalition, whose contracting toolkit cut time to contract by up to 18 months. Now we're carrying that progress past the signature and into care delivery. We're grateful to Omada Health for leading as title sponsor and to the founding partners shaping this work. We're welcoming additional partners! Learn more and get involved: https://lnkd.in/dBbsNar2

Omada Health

1mo

Is GLP-1 weight loss mostly body fat or muscle mass? And does it even matter? Our new 12-week study looked at how body composition changes when people lose weight on GLP-1s, and if Omada’s nutrition and exercise support can help optimize body composition. Read the results here: https://lnkd.in/dUUrZQq9

Omada Health

1mo

Last summer, we celebrated our IPO with a bell-ringing ceremony at Nasdaq headquarters surrounded by family, friends and fellow Omadans. One year later, we may be sentimental, but we're not satisfied. Going public set real change in motion. It has strengthened an already solid financial position and expanded our reach. We've grown to serve more than 2 million members nationwide––and counting. But what hasn't changed is our ambition and our focus. As our CEO Sean Duffy said that day, "It’s a chance to truly swing big and dream big toward helping many tens of millions and to bend the curve of chronic disease.” We continue to partner with leading employers, PBMs and health plans, and to support our members living with obesity and other chronic diseases. Our evidence-based treatment plans, multi-disciplinary care teams, and AI-enhanced insights help us achieve industry-leading clinical outcomes, including in the GLP-1 space. As our footprint grows, so does our responsibility—and our determination—to deliver results that matter, including better outcomes, lower costs, and the trust of our partners and members. Becoming a public company was never the mission. It was a milestone on the way to deepening our impact—because the challenge we’re working to solve hasn’t changed, and our commitment to solving it is only getting stronger. We’re here to bend the curve of chronic disease, one day at a time. #CelebrateOMDA

Omada Health

1mo

You might be wondering, why is a diabetes, weight and heart health provider like Omada talking about kidney disease? Because the American Heart Association's cardiovascular-kidney-metabolic (CKM) health initiative explicitly frames heart disease, kidney disease, diabetes, and obesity as part of a shared syndrome requiring coordinated care. In our latest edition of Proof Points, Senior Clinical Research Scientist Susan Devaraj PhD, RD highlights how many of the same behaviors that protect the heart and help manage blood sugar can also protect the kidneys: She digs into: → Why early kidney disease risk identification should sit alongside diabetes, obesity, and hypertension care. → How lifestyle support that improves blood pressure, glycemic control, and weight can meaningfully reduce kidney disease risk. → The role of scalable, between-visit virtual care in closing equity gaps for high‑risk populations. If you’re responsible for benefits design or population health strategy, this is a must‑read. 👇